HRMY stock news · Harmony Biosciences Holdings, Inc.
Get alerts for HRMY
Follow Harmony Biosciences Holdings, Inc. (HRMY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for HRMYFree on the App Store and Google Play, or on the web.
Harmony Biosciences is losing its President and CEO, with a new one starting on January 1, 2027.
NeutralHarmony Biosciences named its operations chief as CEO for Jan. 1, 2027, while the retiring CEO stays an adviser. The filing adds pay details but no business change.
Harmony Biosciences reveals new findings that bolster its neurology development pipeline.
Good for HRMYHarmony Biosciences' announcement of record revenue and favorable data from its neurology pipeline has led to an 8% increase in its stock price, indicating strong market confidence in its growth trajectory and product potential.